Eastman Chemical (EMN) Receivables - Other (2009 - 2026)

Eastman Chemical (EMN) has reported Receivables - Other for 18 consecutive years, with $268.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Other fell 23.86% year-over-year to $268.0 million; the trailing twelve-month figure through Jun 2026 stood at $268.0 million (down 23.86% YoY), and the FY2025 full-year result was $262.0 million, down 31.23% from the prior year.
• Receivables - Other steadied at $268.0 million in Q2 2026 per EMN's latest filing, from $268.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $461.0 million in Q1 2022 and bottomed at $262.0 million in Q4 2025.
• Historically, Receivables - Other has averaged $340.9 million across 5 years, with a median of $344.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Receivables - Other slumped 41.14% in 2023, then soared 31.91% in 2024.
• Over 5 years, Receivables - Other stood at $320.0 million in 2022, then gained by 2.5% to $328.0 million in 2023, then grew by 16.16% to $381.0 million in 2024, then tumbled by 31.23% to $262.0 million in 2025, then climbed by 2.29% to $268.0 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $268.0 million, $268.0 million, and $262.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.